ENOV Enovis Corporation

Enovis is a medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Our mission is to fuel active lifestyles in orthopedics and beyond.

$56.00  +1.00 (1.82%)
As of 07/01/2022 16:00:50 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Specialty Industrial Machinery
Index country:  USA
Country of incorporation:  USA
IPO date:  05/08/2008
Outstanding shares:  54,030,880
Average volume:  433,333
Market cap:   $2,971,698,400
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BJLTMX5

---

Valuation   (See tab for details)

---

PE ratio:   44.73
PB ratio:   0.66
PS ratio:   0.74
Return on equity:   1.47%
Net income %:   1.69%